Literature DB >> 4136969

Letter: Penicillinase production by Haemophilus influenzae.

J D Williams, S Kattan, P Cavanagh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4136969     DOI： 10.1016/s0140-6736(74)91663-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Characterization of an ampicillin-resistant Haemophilus influenzae type B.

Authors:  T C Eickhoff; J M Ehret; R D Baines
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

2.  Ampicillin-resistant strains of Hemophilus influenzae.

Authors:  R P Larke; L Chicoine; P Déry; S E Johnson; V Marchessault; A Marcoux; M I Marks; G Martineau; P J Middleton; J D Murray; R I Ozere; H Pabst; A R Ronald; M C Smith
Journal:  Can Med Assoc J       Date:  1975-08-09       Impact factor: 8.262

Review 3.  Haemophilus influenzae: antibiotic susceptibility.

Authors:  C A Needham
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

4.  In vitro susceptibility of Haemophilus influenzae to cefixime.

Authors:  M Powell; J D Williams
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191

Review 5.  Mechanisms of beta-lactam resistance in Haemophilus influenzae.

Authors:  L Gutmann; R Williamson; E Collatz; J F Acar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-10       Impact factor: 3.267

Review 6.  In vitro antibacterial effects of cephalosporins.

Authors:  J D Williams; F Moosdeen
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 7.  Mechanisms of resistance to cephalosporin antibiotics.

Authors:  D M Livermore
Journal:  Drugs       Date:  1987       Impact factor: 9.546

8.  Antimicrobial resistance among clinical isolates of Haemophilus influenzae in northern Italy. Collaborative Study on Pediatric Infectious Diseases.

Authors:  M L Garlaschi; F Rusconi; R Colombo; F Conio; S Sideri; F Varotto; M Arghittu; C Passerini; A Sala
Journal:  Eur J Epidemiol       Date:  1993-01       Impact factor: 8.082
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.